| Literature DB >> 29928860 |
Peter G Adams1, Cvetelin Vasilev2, C Neil Hunter2, Matthew P Johnson2.
Abstract
Light-Harvesting Complex II (LHCII) is a chlorophyll-protein antenna complex that efficiently absorbs solar energy and transfers electronic excited states to photosystems I and II. Under excess light intensity LHCII can adopt a photoprotective state in which excitation energy is safely dissipated as heat, a process known as Non-Photochemical Quenching (NPQ). In vivo NPQ is triggered by combinatorial factors including transmembrane ΔpH, PsbS protein and LHCII-bound zeaxanthin, leading to dramatically shortened LHCII fluorescence lifetimes. In vitro, LHCII in detergent solution or in proteoliposomes can reversibly adopt an NPQ-like state, via manipulation of detergent/protein ratio, lipid/protein ratio, pH or pressure. Previous spectroscopic investigations revealed changes in exciton dynamics and protein conformation that accompany quenching, however, LHCII-LHCII interactions have not been extensively studied. Here, we correlated fluorescence lifetime imaging microscopy (FLIM) and atomic force microscopy (AFM) of trimeric LHCII adsorbed to mica substrates and manipulated the environment to cause varying degrees of quenching. AFM showed that LHCII self-assembled onto mica forming 2D-aggregates (25-150 nm width). FLIM determined that LHCII in these aggregates were in a quenched state, with much lower fluorescence lifetimes (~0.25 ns) compared to free LHCII in solution (2.2-3.9 ns). LHCII-LHCII interactions were disrupted by thylakoid lipids or phospholipids, leading to intermediate fluorescent lifetimes (0.6-0.9 ns). To our knowledge, this is the first in vitro correlation of nanoscale membrane imaging with LHCII quenching. Our findings suggest that lipids could play a key role in modulating the extent of LHCII-LHCII interactions within the thylakoid membrane and so the propensity for NPQ activation.Entities:
Keywords: Atomic force microscopy (AFM); Light harvesting; Light-Harvesting Complex II (LHCII); Non-photochemical quenching (NPQ); Photosynthesis; Time-resolved fluorescence
Year: 2018 PMID: 29928860 PMCID: PMC6135645 DOI: 10.1016/j.bbabio.2018.06.011
Source DB: PubMed Journal: Biochim Biophys Acta Bioenerg ISSN: 0005-2728 Impact factor: 3.991
Fig. 1Purification of LHCII trimers. Standard denaturing SDS-PAGE of LHCII samples either with Coomassie staining (A), or more sensitive Sypro Ruby fluorescent staining (equivalent detection to silver staining) (B), or the non-denaturing Clear Native PAGE (C). Pre-stained protein standards (X), crude thylakoid membranes after α-DDM solubilisation (Thy), LHCII after isolation on sucrose density gradients (1), LHCII trimers after addition purification by size exclusion FPLC chromatography (2). The position of the band expected to represent trimeric or monomeric LHCII is indicated (Tri or Mon, respectively). (D) Cuvette-based absorption spectrum (blue) and overlaid fluorescence emission scan (red) of LHCII at 10 nM LHCII (in 0.03% α-DDM, 20 mM HEPES, pH 7.5). Excitation at 473 nm with slit width = 4 nm, emission slit width = 1 nm. (E) Cuvette-based time-resolved fluorescence measurement of the same LHCII sample produced a fluorescence decay curve as shown, average lifetime = 3.85 ns (see Table 1). Excitation with 473 nm pulsed laser, emission slit width = 1 nm. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Analysis of FLIM data comparing the fluorescence lifetime of LHCII on mica.
| Sample [LHCII] (nM) | Lipids/DDM? | Excitation fluence (mJ/cm2) | A1 (%) | A2 (%) | 〈 | 〈 | ||
|---|---|---|---|---|---|---|---|---|
| 10 | DDM | 0.39 | 98 | 3.73 | 2 | 8.96 | 3.85 | N/A |
| 1000 | DDM | 0.39 | 49 | 3.32 | 51 | 1.17 | 2.22 | 0.04 |
| 200 | None | 0.39 | 24 | 0.35 | 76 | 0.19 | 0.23 | 0.07 |
| 400 | None | 0.39 | 4 | 0.70 | 96 | 0.21 | 0.22 | 0.02 |
| 600 | None | 0.39 | 2 | 1.08 | 98 | 0.21 | 0.23 | 0.02 |
| 800 | None | 0.39 | 3 | 1.26 | 97 | 0.24 | 0.27 | 0.01 |
| 1000 | None | 0.39 | 2 | 1.28 | 98 | 0.23 | 0.26 | 0.02 |
| 200 | None | 0.05 | 41 | 0.32 | 59 | 0.19 | 0.23 | 0.04 |
| 400 | None | 0.05 | 24 | 0.30 | 76 | 0.19 | 0.21 | 0.03 |
| 600 | None | 0.05 | 14 | 0.32 | 86 | 0.18 | 0.20 | 0.03 |
| 800 | None | 0.05 | 23 | 0.30 | 77 | 0.19 | 0.22 | 0.03 |
| 1000 | None | 0.05 | 29 | 0.38 | 71 | 0.25 | 0.29 | 0.04 |
| 400 | PC lipids | 0.39 | 19 | 2.04 | 81 | 0.60 | 0.86 | 0.08 |
| 600 | PC lipids | 0.39 | 16 | 1.68 | 84 | 0.56 | 0.73 | 0.04 |
| 800 | PC lipids | 0.39 | 21 | 1.33 | 79 | 0.47 | 0.65 | 0.04 |
| 1000 | PC lipids | 0.39 | 18 | 1.84 | 82 | 0.58 | 0.81 | 0.03 |
| 400 | PC lipids | 0.05 | 33 | 1.46 | 67 | 0.72 | 0.96 | 0.08 |
| 600 | PC lipids | 0.05 | 17 | 1.56 | 83 | 0.75 | 0.88 | 0.04 |
| 800 | PC lipids | 0.05 | 33 | 1.35 | 67 | 0.73 | 0.93 | 0.06 |
| 1000 | PC lipids | 0.05 | 26 | 1.51 | 74 | 0.60 | 0.82 | 0.07 |
| 400 | Thy lipids | 0.39 | 6 | 2.34 | 94 | 0.53 | 0.65 | 0.06 |
| 600 | Thy lipids | 0.39 | 6 | 1.70 | 94 | 0.51 | 0.58 | 0.02 |
| 800 | Thy lipids | 0.39 | 14 | 1.25 | 86 | 0.47 | 0.56 | 0.11 |
| 1000 | Thy lipids | 0.39 | 8 | 1.78 | 92 | 0.51 | 0.61 | 0.03 |
Fitted lifetime components (τ) are expressed in terms of their percentage amplitudes (A).
〈τ〉 is the amplitude-weight average lifetime, standard deviation shown, 8 measurements per sample (except for c, n = 3, where signal/noise was very high).
Fitted z-parameter was always approx. 0.1–0.2% of (A1 + A2), is not discussed further.
Denotes concentration of LHCII solution incubated with mica surface for 20 min followed by washing surface with copious buffer to remove unbound protein, except for (b).
Control sample, lifetimes measured from 10 nM LHCII in high-detergent solution using a cuvette-based spectrophotometer, data from Fig. 1E (all other samples measured using FLIM).
Control sample, lifetimes measured from 1000 nM LHCII in low-detergent solution above mica (~5 μm).
Incubated with DOPC lipid vesicles (600 μM) for 20 min, following LHCII adsorption to mica.
Incubated with thylakoid lipid vesicles (600 μM) for 20 min, following LHCII adsorption to mica.
Excitation fluence was calculated from the measured average power, known repetition rate and pulse FWHM and estimated losses (for full details, see Supplementary Fig. S1).
Fig. 2Visualization of the aggregated domains of LHCII by atomic force microscopy. (A)–(D): Representative AFM topographs showing the arrangements formed by deposition of LHCII onto mica substrates for 20 min at a range of LHCII concentration from 1000 to 100 nM. Substrates were washed with buffer prior to imaging. (E) High resolution topograph showing LHCII trimers and height profiles (below). (F) 3-D representation of (E). (G) Graph showing the area of the substrate occupied by LHCII (% of total) vs concentration of LHCII applied.
Fig. 3Fluorescence lifetime and spectral imaging microscopy (FLIM) of LHCII on mica under detergent, as aggregates (without lipid), and with lipids.
(A) Representative epifluorescence images of LHCII on mica as aggregates, LHCII (aggr.) (deposited at 1000 nM LHCII trimers for 20 min, washed), or after incubation with lipid vesicles and gentle washing, LHCII (DOPC) (600 μM lipids for 20 min). Image brightness was increased for LHCII (aggr.) to be comparable for clarity. (B) Fluorescence emission spectra acquired of representative diffraction-limited regions from each sample. The alternative lipid sample using thylakoid lipid vesicles is denoted as LHCII (Thy) and the additional control sample of LHCII in detergent solution ~5 μm above mica are also shown, LHCII (DDM). (C) Picosecond time-resolved fluorescence decay curves of representative regions from samples. Bi-exponential curve fitting (solid black lines) and residuals shown, labelled as in (B). The Instrument Response Function (IRF) is shown (dotted line), with a measured full-width at half-maximum (FWHM) of ~170 ps. All decay curves normalized to a maximum of 1000 counts (dividing raw data for DDM, DOPC, Thy and aggr. by 8.64, 2.44, 2.06 and 1.15, respectively). Arrows represent the proposed process (1): the deposition of LHCII onto mica and aggregation-induced faster decay, and process (2): addition of lipids causing limited dis-aggregation and slower decay. Note, only regions of homogeneous fluorescence in observed in LHCII (lipids) were analysed in (B) and (C) for reproducibility, bright spots were avoided. All samples were measured under N2-sparged buffer solution containing the oxygen-scavenging system of PCD/PCA. (D) Graph showing the average fluorescence lifetime 〈τ〉 against the concentration of LHCII incubated with mica, as in Table 1.
Fig. 4LHCII domains on mica before and after addition of lipids.
(A) AFM topograph of aggregated LHCII domains (deposited at 600 nM for 20 min, washed). (C) AFM topograph of a parallel sample to (A), but after incubation with DOPC lipid vesicles (600 μM for 20 min) and gentle washing. (E) AFM topograph of aggregated LHCII domains (deposited at 1000 nM for 20 min, washed with salts). (G) AFM topograph of a parallel sample to (E), but after incubation with thylakoid lipid vesicles (600 μM for 20 min) and gentle washing. (B), (D), (F), (H) Higher magnification regions of (A), (C), (E), and (G), respectively, with height profiles (below). (I) Series of height profiles across representative LHCII protrusions. Red: across LHCII in aggregates from (A); or blue: across LHCII in DOPC SLBs from (C). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Analysis of AFM measurements comparing the effect of lipid membranes on LHCII organisation on mica.
| Sample [LHCII] (nM) | Lipids/DDM? | Surface coverage with LHCII ± S.D. (% total substrate area) | Nearest neighbour LHCII distance ± S.D. (nm) |
|---|---|---|---|
| 600 | None | 27.9 ± 1.6 | 10.5 ± 2.2 |
| 600 | Lipids | 14.2 ± 1.4 | 13.5 ± 2.1 |
Denotes concentration of LHCII solution incubated with mica surface for 20 min followed by washing surface with copious buffer to remove unbound protein.
Incubated with DOPC lipid vesicles for 20 min, following LHCII adsorption to mica.
Mean of at least 4 AFM images taken of different regions of the substrate, standard deviation (S.D.) shown.
Mean of well-resolved LHCII-LHCII pairs, S.D. shown (n = 49, 51, respectively).
Fig. 5Schematic of possible arrangements of LHCII on mica.
Cartoon representation showing how LHCII in 2-D aggregates on a surface (with a possible detergent perimeter) has low fluorescence (quenched state) because of self-associations due to tight packing, in comparison to the greater LHCII separation we observe when in a lipid bilayer and greater fluorescence (less quenched). These interactions are likely to be driven by thermodynamics and the hydrophobic effect, shielding apolar regions of the protein from water. These AFM images (adapted from Fig. 4, all to scale) were acquired on the same day with the same AFM probe and are therefore highly comparable and “more space” around LHCII is apparent with lipids. Positions of LHCII were estimated for this cartoon based on space-filling requirements where AFM resolution is imperfect.